Artificial intelligence (AI) is being seen by the Indian healthcare industry as a strategic necessity that will enable next-generation treatments and increase systemic efficiency throughout the industry
Tata Elxsi, a global leader in design and technology services, announced the inauguration of the ‘Bayer Development Centre in Radiology’ at Tata Elxsi, Pune, India
Emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA), has been given Fast Track designation by the U.S. Food and Drug Administration (FDA), according to a statement released today by Teva Pharmaceuticals
The U.S. Food and Drug Administration (FDA) has approved Inlexzo, the first drug delivery system from Johnson & Johnson, for patients with high-risk non-muscle invasive bladder cancer who have failed standard Bacillus Calmette-Guerin (BCG) therapy...
Today Eli Lilly and Company announced Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that enables biotech firms to access sophisticated models for drug discovery based on decades of Lilly data...
Sun Pharmaceutical Industries declared that the US Food and Drug Administration (USFDA) has moved its Halol manufacturing plant in Gujarat to Official Action Indicated (OAI). The decision follows by the detailed examination.
Pfizer Inc. and BioNTech SE announced promising topline findings from a phase 3 study of their LP.8.1-adapted Comirnaty Covid-19 vaccine (2025-2026 Formula) that targets the SARS-CoV-2 evolution. The study involved adults aged 65 and older and...
Amit Agrawal, Secretary, Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, Government of India (GoI), highlighted the quantum jump by Indian Medical Devices sector and reiterated commitment to support the industry...
Alembic Pharmaceuticals (Alembic) announced the receipt of final approval by the US Food & Drug Administration
Baxdrostat is a new blood pressure medication created by AstraZeneca that has been seen to lower the risk of cardiovascular in patients with resistant hypertension